|
WO2021041624A2
|
|
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
US2020237899A1
|
|
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
US2019167781A1
|
|
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
WO2013032942A1
|
|
Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
|
|
US2011110978A1
|
|
High titer recombinant influenza viruses with enhanced replication in vero cells
|
|
US2011081373A1
|
|
Influenza A virus with attenuating mutations in NS2 protein
|
|
US2011263554A1
|
|
Screen for inhibitors of filovirus and uses therefor
|
|
WO2008156778A2
|
|
Influenza m2 protein mutant viruses as live influenza attenuated vaccines
|
|
WO2008156681A2
|
|
Adenoviral vectors for influenza virus production
|
|
US2009324640A1
|
|
Neuraminidase-deficient live influenza vaccines
|
|
US2008293040A1
|
|
Influenza B viruses with reduced sensitivity to neuraminidase inhibitors
|
|
US8715940B2
|
|
Method of making recombinant influenza virus
|
|
WO0179273A2
|
|
Viruses comprising mutated ion channel protein
|
